REQUEST A DEMO
Total
USD $0.00
Search more companies

Medikorfarma-Ural OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medikorfarma-Ural OOO Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Medikorfarma-Ural OOO is an enterprise in Russia, with the main office in Ekaterinburg. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 21, 2011. 15 (2023) employees currently work for Medikorfarma-Ural OOO. In its most recent financial highlights, the company reported a net sales revenue increase of 1.02% in 2023. Over the same period, its total assets grew by 5.94%. The enterprise’s net profit margin decreased by 10.19% in 2023.

Headquarters
Kraulya, 2, 192
Ekaterinburg; Sverdlovsk Oblast; Postal Code: 620028

Contact Details: Purchase the Medikorfarma-Ural OOO report to view the information.

Basic Information
Total Employees:
Purchase the Medikorfarma-Ural OOO report to view the information.
Outstanding Shares:
Purchase the Medikorfarma-Ural OOO report to view the information.
Registered Capital:
Purchase the Medikorfarma-Ural OOO report to view the information.
Incorporation Date:
July 21, 2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medikorfarma-Ural OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
1.02%
Total operating revenue
1.02%
Operating profit (EBIT)
254.82%
Net Profit (Loss) for the Period
-51.27%
Total assets
5.94%
Total equity
6.76%
Operating Profit Margin (ROS)
7.44%
Net Profit Margin
-10.19%
Return on Equity (ROE)
-27.23%
Quick Ratio
-0.46%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?